AU:EZZ Life Science Holdings Ltd. Issues New Shares to Sophisticated Investor in Compliance with Legal Provisions

AU:EZZ Life Science Holdings Ltd., an Australian genomic life science company, recently announced the issuance of 1,708,200 new shares to a sophisticated investor at $0.50 each. The transaction was carried out under section 708A(5)(e) of the Corporations Act, which allows for the shares to be issued without disclosure to investors.

The company, which has a focus on addressing significant health challenges and a strong e-commerce presence, has confirmed its compliance with all legal provisions. No excluded information was required to be disclosed in this notice.

If you are interested in learning more about AU:EZZ stock, TipRanks’ Stock Analysis page can provide further insights.